Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx HealthcareTSE:2689 62 Piotroski F-Score is 3 as of Sep. 19, 2026, which is 40% below its 10-year median of 5.00. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,164.52 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 117 Medical Distribution companies, Olba DVx Healthcare ranks worse than 81.2% on this metric.
Warning Sign:
Piotroski F-Score of 3 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Olba DVx Healthcare has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
The historical rank and industry rank for Olba DVx Healthcare's Piotroski F-Score or its related term are showing as below:
TSE:2689'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 5 Max: 9
Current: 3
During the past 13 years, the highest Piotroski F-Score of Olba DVx Healthcare was 9. The lowest was 3. And the median was 5.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Olba DVx Healthcare Piotroski F-Score Related Terms
Olba DVx Healthcare Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2689 vs MCK, COR, CAH: Piotroski F-Score Comparison
For the Medical Distribution subindustry, Olba DVx Healthcare's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare Piotroski F-Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Olba DVx Healthcare's current Net Income (TTM) was 1,112.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Olba DVx Healthcare's return on assets of this year was 0.02425122. Olba DVx Healthcare's return on assets of last year was 0.03307567.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Olba DVx Healthcare's gearing of this year was 0.04092046. Olba DVx Healthcare's gearing of last year was 0.05389997.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Olba DVx Healthcare's current ratio of this year was 1.23290794. Olba DVx Healthcare's current ratio of last year was 1.23814465.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Olba DVx Healthcare's number of shares in issue this year was 5.928. Olba DVx Healthcare's number of shares in issue last year was 5.923.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Olba DVx Healthcare's gross margin of this year was 0.11199936. Olba DVx Healthcare's gross margin of last year was 0.11335554.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Olba DVx Healthcare's asset turnover of this year was 2.75980543. Olba DVx Healthcare's asset turnover of last year was 2.83789145.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
0
+
1
+
0
+
0
+
0
+
0
=
3
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Olba DVx Healthcare has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
Olba DVx Healthcare (TSE:2689) has a Piotroski F-Score of 3 as of Sep. 19, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Olba DVx Healthcare and its competitors. This is 40% below median its historical median of 5.00. Over the past decade, Olba DVx Healthcare's Piotroski F-Score has ranged from 3.00 to 9.00. According to the industry distribution chart, Olba DVx Healthcare ranks #95 out of 117 companies in the Medical Distribution industry, placing it in the top 81.2%.
Is Olba DVx Healthcare's Piotroski F-Score too high?
Olba DVx Healthcare's current Piotroski F-Score of 3 is 40% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Olba DVx Healthcare's value of 3 is 40% below this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #95 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's Piotroski F-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #95 out of 117 companies for Piotroski F-Score. This places Olba DVx Healthcare in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Olba DVx Healthcare's value of 3 is 40% below this benchmark. Historically, Olba DVx Healthcare's own Piotroski F-Score has ranged from 3.00 to 9.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Olba DVx Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current Piotroski F-Score is 3, which is 40% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.52, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current Piotroski F-Score is 3, which is 40% below median its 10-year median of 5.00 and 40% below the Medical Distribution industry median of 5.00. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current Piotroski F-Score is 3 as of Sep. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.52.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
Piotroski F-Score: 3 (40% below median its 10-year median of 5.00)
GF Value™: 円2,164.52 vs. price of 円1,925.00 (11.1% below fair value)
Industry Position: 40% below the Medical Distribution median (#95 of 117)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
